Research location
Bhopal
Madhya Pradesh, India
Advertisement
Research activity in Bhopal
Madhya Pradesh, IndiaCureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 19 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Bhopal
19 linked trials · page 1 of 1Levels of Inflammation in People With Cardiovascular Disease (POSEIDON)NCT06122961 · 2023-11-23 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisNCT06025578 · 2023-10-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.NCT05110196 · 2022-09-03 · 1 site observation
COMPLETED
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed on or After Endocrine TreatmentNCT05631795 · 2022-08-09 · 1 site observation
COMPLETED
Study of PIK3CA Mutations and Effectiveness and Tolerability Outcomes of Alpelisib in Real-worldNCT05022342 · 2021-10-27 · 1 site observation
COMPLETED
A Study of BIO-11006 in the Treatment of Advanced Non-Small Cell Lung CancerNCT03472053 · 2018-02-01 · 1 site observation
COMPLETED
Indian Phenotype RegistryNCT03363594 · 2017-12-11 · 1 site observation
COMPLETED
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes MellitusNCT02773368 · 2016-05-23 · 1 site observation
COMPLETED
Study to Understand Usage and Effect of Saxagliptin as First Add-On After Metformin in Indian Type 2 Diabetes Mellitus PatientsNCT02588859 · 2015-10-30 · 1 site observation
COMPLETED
A Non-interventional, Post Marketing Surveillance (PMS) Study of Tresiba® (Insulin Degludec) to Evaluate Long Term Safety and Efficacy in Patients With Diabetes Mellitus in Routine Clinical Practice in IndiaNCT02117622 · 2015-07-24 · 1 site observation
COMPLETED
A Non-Interventional Study To Evaluate Diabetes Related Quality Of Life, Frequency And Impact Of Hypoglycemia In T2DMNCT01523405 · 2012-03-01 · 1 site observation
COMPLETED
Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast CancerNCT00915018 · 2009-08-21 · 1 site observation
COMPLETED
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving ChemotherapyNCT00858364 · 2009-07-17 · 1 site observation
TERMINATED
Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusNCT00856284 · 2009-03-01 · 1 site observation
COMPLETED
TC-5214 as add-on the Treatment of Major Depressive DisorderNCT00692445 · 2008-06-01 · 1 site observation
COMPLETED
A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC)NCT00682981 · 2008-05-01 · 1 site observation
COMPLETED
A Clinical Study to Evaluate the Effect of Naturlose (Tagatose)NCT00961662 · 2008-02-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerNCT00617669 · 2008-01-01 · 1 site observation
COMPLETED
A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone MetastasesNCT00554229 · 2007-11-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.